{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T04:30:53Z","timestamp":1774326653377,"version":"3.50.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1007\/s11010-016-2864-1","type":"journal-article","created":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T08:25:06Z","timestamp":1477988706000},"page":"85-93","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Receptor-mediated toxicity of human amylin fragment aggregated by short- and long-term incubations with copper ions"],"prefix":"10.1007","volume":"425","author":[{"given":"Giuseppe","family":"Caruso","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donatella A.","family":"Distefano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Parlascino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia G.","family":"Fresta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5917-7279","authenticated-orcid":false,"given":"Giuseppe","family":"Lazzarino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan M.","family":"Lunte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo G.","family":"Nicoletti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,11,1]]},"reference":[{"key":"2864_CR1","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0140-6736(97)02073-4","volume":"350","author":"RW Carrell","year":"1997","unstructured":"Carrell RW, Lomas DA (1997) Conformational disease. Lancet 350:134\u2013138","journal-title":"Lancet"},{"key":"2864_CR2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0959-440X(96)80089-3","volume":"6","author":"JW Kelly","year":"1996","unstructured":"Kelly JW (1996) Alternative conformations of amyloidogenic proteins govern their behavior. Curr Opin Struct Biol 6:11\u201317","journal-title":"Curr Opin Struct Biol"},{"key":"2864_CR3","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1021\/cr040410w","volume":"106","author":"E Gaggelli","year":"2006","unstructured":"Gaggelli E, Kozlowski H, Valensin D, Valensin G (2006) Copper homeostasis and neurodegenerative disorders (Alzheimer\u2019s, prion, and Parkinson\u2019s diseases and amyotrophic lateral sclerosis). Chem Rev 106:1995\u20132044","journal-title":"Chem Rev"},{"key":"2864_CR4","first-page":"61","volume":"18","author":"R Prager","year":"1991","unstructured":"Prager R, Ludvik B, Hartter E (1991) Role of amylin in the pathogenesis of type II diabetes mellitus. Acta Med Austriaca 18:61\u201362","journal-title":"Acta Med Austriaca"},{"key":"2864_CR5","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0925-4439(01)00078-3","volume":"1537","author":"S Jaikaran","year":"2001","unstructured":"Jaikaran S, Clark A (2001) Islet amyloid and type 2 diabetes: from molecular misfolding to islet pathophysiology. Biochim Biophys Acta 1537:179\u2013203","journal-title":"Biochim Biophys Acta"},{"key":"2864_CR6","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.sbi.2007.01.007","volume":"17","author":"R Kodali","year":"2007","unstructured":"Kodali R, Wetzel R (2007) Polymorphism in the intermediates and products of amyloid assembly. Curr Opin Struc Biol 17:48\u201357","journal-title":"Curr Opin Struc Biol"},{"key":"2864_CR7","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.chembiol.2005.05.010","volume":"12","author":"M Tatarek-Nossol","year":"2005","unstructured":"Tatarek-Nossol M, Yan LM, Schmauder A, Tenidis K, Westermark G, Kapurniotu A (2005) Inhibition of hIAPP amyloid-fibril formation and apoptotic cell death by a designed hIAPP amyloid-core-containing hexapeptide. Chem Biol 12:797\u2013809","journal-title":"Chem Biol"},{"key":"2864_CR8","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1021\/bm101159p","volume":"12","author":"J Zhao","year":"2011","unstructured":"Zhao J, Yu X, Liang G, Zheng J (2011) Structural polymorphism of human islet amyloid polypeptide (hIAPP) oligomers highlights the importance of interfacial residue interactions. Biomacromolecules 12:210\u2013220","journal-title":"Biomacromolecules"},{"key":"2864_CR9","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1006\/jmbi.1999.3422","volume":"295","author":"K Tenidis","year":"2000","unstructured":"Tenidis K, Waldner M, Bernhagen J, Fischle W, Bergmann M, Weber M, Merkle ML, Voelter ML, Brunner H, Kapurniotu A (2000) Identification of a penta- and hexapeptide of islet amyloid polypeptide (IAPP) with amyloidogenic and cytotoxic properties. J Mol Biol 295:1055\u20131071","journal-title":"J Mol Biol"},{"key":"2864_CR10","doi-asserted-by":"crossref","first-page":"10204","DOI":"10.1002\/chem.200700576","volume":"13","author":"G Pappalardo","year":"2007","unstructured":"Pappalardo G, Milardi D, Magr\u00ec A, Attanasio F, Impellizzeri G, La Rosa C, Grasso D, Rizzarelli E (2007) Environmental factors differently affect human and rat IAPP: conformational preferences and membrane interactions of IAPP17-29 peptide derivatives. Chemistry 13:10204\u201310215","journal-title":"Chemistry"},{"key":"2864_CR11","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1021\/jp908436s","volume":"114","author":"A Mazzaglia","year":"2010","unstructured":"Mazzaglia A, Micali N, Scolaro LM, Attanasio F, Magr\u00ed A, Pappalardo G, Villari V (2010) Aggregation properties of the peptide fragments derived from the 17 to 29 region of the human and rat IAPP: a comparative study with two PEG-conjugated variants of the human sequence. J Phys Chem B 114:705\u2013713","journal-title":"J Phys Chem B"},{"key":"2864_CR12","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1021\/ja076282l","volume":"130","author":"D Noy","year":"2008","unstructured":"Noy D, Solomonov I, Sinkevich O, Arad T, Kjaer K, Sagi I (2008) Zinc-amyloid beta interactions on a millisecond time-scale stabilize non-fibrillar Alzheimer-related species. J Am Chem Soc 130:1376\u20131383","journal-title":"J Am Chem Soc"},{"key":"2864_CR13","doi-asserted-by":"crossref","first-page":"e1378","DOI":"10.1371\/journal.pone.0001378","volume":"3","author":"PG Ridge","year":"2008","unstructured":"Ridge PG, Zhang Y, Gladyshev VN (2008) Comparative genomic analyses of copper transporters and cupro proteomes reveal evolutionary dynamics of copper utilization and its link to oxygen. PLoS ONE 3:e1378","journal-title":"PLoS ONE"},{"key":"2864_CR14","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jinorgbio.2007.09.010","volume":"102","author":"B Ward","year":"2008","unstructured":"Ward B, Walker K, Exley C (2008) Copper(II) inhibits the formation of amylin amyloid in vitro. J Inorg Biochem 102:371\u2013375","journal-title":"J Inorg Biochem"},{"key":"2864_CR15","doi-asserted-by":"crossref","first-page":"4","DOI":"10.7243\/2050-0866-4-4","volume":"4","author":"M Mold","year":"2015","unstructured":"Mold M, Bunrat C, Goswami P, Roberts A, Roberts C, Taylor N, Taylor H, Wu L, Fraser PE, Exley C (2015) Further insight into the role of metals in amyloid formation by IAPP1-37 and ProIAPP1-48. J Diab Res Clin Met 4:4","journal-title":"J Diab Res Clin Met"},{"key":"2864_CR16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.7243\/2050-0866-1-3","volume":"1","author":"C Exley","year":"2012","unstructured":"Exley C, Mold M, Shardlow E, Shuker B, Ikpe B, Wu L, Fraser PE (2012) Copper is a potent inhibitor of the propensity for human ProIAPP1-48 to form amyloid fibrils in vitro. J Diabetes Res Clin Metab 1:3","journal-title":"J Diabetes Res Clin Metab"},{"key":"2864_CR17","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1016\/j.febslet.2007.06.061","volume":"581","author":"A Masad","year":"2007","unstructured":"Masad A, Hayes L, Tabner BJ, Turnbull S, Cooper LJ, Fullwood NJ, German MJ, Kametani F, El-Agnaf OMA, Allsop D (2007) Copper mediated formation of hydrogen peroxide from the amylin peptide: a novel mechanism for degeneration of islet cells in type-2 diabetes mellitus? FEBS Lett 581:3489\u20133493","journal-title":"FEBS Lett"},{"key":"2864_CR18","doi-asserted-by":"crossref","first-page":"6909","DOI":"10.1039\/c0cc02141e","volume":"46","author":"YP Yu","year":"2010","unstructured":"Yu YP, Lei P, Hu J, Wu WH, Zhao YF, Li YM (2010) Copper-induced cytotoxicity: reactive oxygen species or islet amyloid polypeptide oligomer formation. Chem Commun 46:6909\u20136911","journal-title":"Chem Commun"},{"key":"2864_CR19","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1042\/BST0331082","volume":"33","author":"BJ Tabner","year":"2005","unstructured":"Tabner BJ, El-Agnaf OMA, German MJ, Fullwood NJ, Allsop D (2005) Protein aggregation, metals and oxidative stress in neurodegenerative diseases. Biochem Soc Trans 33:1082\u20131086","journal-title":"Biochem Soc Trans"},{"key":"2864_CR20","first-page":"129","volume":"23","author":"S Yamagishi","year":"2003","unstructured":"Yamagishi S, Takeuchi M, Inagaki Y, Nakamura K, Imaizumi T (2003) Role of advanced glycation end products (AGEs) and their receptor (RAGE) in the pathogenesis of diabetic microangiopathy. Int J Clin Pharmacol Res 23:129\u2013134","journal-title":"Int J Clin Pharmacol Res"},{"key":"2864_CR21","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1749-6632.2011.06320.x","volume":"1243","author":"R Ramasamy","year":"2011","unstructured":"Ramasamy R, Yan SF, Schmidt AM (2011) Receptor for AGE (RAGE): signalling mechanisms in the pathogenesis of diabetes and its complications. Ann N Y Acad Sci 1243:88\u2013102","journal-title":"Ann N Y Acad Sci"},{"key":"2864_CR22","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1007\/s00018-002-8491-x","volume":"59","author":"LG Bucciarelli","year":"2002","unstructured":"Bucciarelli LG, Wendt T, Rong L, Lalla E, Hofmann MA, Goova MT, Taguchi A, Yan SF, Yan SD, Stern DM, Schmidt AM (2002) RAGE is a multiligand receptor of the immunoglobulin superfamily: implications for homeostasis and chronic disease. Cell Mol Life Sci 59:1117\u20131128","journal-title":"Cell Mol Life Sci"},{"key":"2864_CR23","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/sj.ki.5002305","volume":"72","author":"W Gong","year":"2007","unstructured":"Gong W, Liu ZH, Zeng CH, Peng A, Chen HP, Zhou H, Li LS (2007) Amylin deposition in the kidney of patients with diabetic nephropathy. Kidney Int 72:213\u2013218","journal-title":"Kidney Int"},{"key":"2864_CR24","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1093\/emboj\/cdg254","volume":"22","author":"AM Davies","year":"2003","unstructured":"Davies AM (2003) Regulation of neuronal survival and death by extracellular signals during development. EMBO J 22:2537\u20132545","journal-title":"EMBO J"},{"key":"2864_CR25","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/ana.23956","volume":"74","author":"K Jackson","year":"2013","unstructured":"Jackson K, Barisone GA, Diaz E, Jin LW, DeCarli C, Despa F (2013) Amylin deposition in the brain: a second amyloid in Alzheimer disease? Ann Neurol 74:517\u2013526","journal-title":"Ann Neurol"},{"key":"2864_CR26","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1750-1326-9-30","volume":"9","author":"S Srodulski","year":"2014","unstructured":"Srodulski S, Sharma S, Bachstetter AB, Brelsfoard JM, Pascual C, Xie XS, Saatman KE, Van Eldik LJ, Despa F (2014) Neuroinflammation and neurologic deficits in diabetes linked to brain accumulation of amylin. Mol Neurodegener 9:30","journal-title":"Mol Neurodegener"},{"key":"2864_CR27","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jsb.2005.06.006","volume":"151","author":"R Khurana","year":"2005","unstructured":"Khurana R, Coleman C, Ionescu-Zanetti C, Carter SA, Krishna V, Grover RK, Roy R, Singh S (2005) Mechanism of thioflavin T binding to amyloid fibrils. J Struct Biol 151:229\u2013238","journal-title":"J Struct Biol"},{"key":"2864_CR28","doi-asserted-by":"crossref","first-page":"14745","DOI":"10.1073\/pnas.0905127106","volume":"106","author":"K Ono","year":"2009","unstructured":"Ono K, Condron MM, Teplow DB (2009) Structure-neurotoxicity relationships of amyloid beta-protein oligomers. Proc Natl Acad Sci USA 106:14745\u201314750","journal-title":"Proc Natl Acad Sci USA"},{"key":"2864_CR29","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/pro.5560020312","volume":"2","author":"H LeVine 3rd","year":"1993","unstructured":"LeVine H 3rd (1993) Thioflavine T interaction with synthetic Alzheimer\u2019s disease beta-amyloid peptides: detection of amyloid aggregation in solution. Protein Sci 2:404\u2013410","journal-title":"Protein Sci"},{"key":"2864_CR30","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s11626-014-9823-5","volume":"51","author":"X Wang","year":"2015","unstructured":"Wang X, Yu S, Wang CY, Wang Y, Liu HX, Cui Y, Zhang LD (2015) Advanced glycation end products induce oxidative stress and mitochondrial dysfunction in SH-SY5Y cells. In Vitro Cell Dev Biol Anim 51:204\u2013209","journal-title":"In Vitro Cell Dev Biol Anim"},{"key":"2864_CR31","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1039\/c3fo60097a","volume":"4","author":"AK Holik","year":"2013","unstructured":"Holik AK, Rohm B, Somoza MM, Somoza V (2013) N(\u03b5)-Carboxymethyllysine (CML), a Maillard reaction product, stimulates serotonin release and activates the receptor for advanced glycation end products (RAGE) in SH-SY5Y cells. Food Funct 4:1111\u20131120","journal-title":"Food Funct"},{"key":"2864_CR32","doi-asserted-by":"crossref","first-page":"915","DOI":"10.3233\/JAD-2010-1288","volume":"19","author":"B Chakravarthy","year":"2010","unstructured":"Chakravarthy B, Gaudet C, M\u00e9nard M, Atkinson T, Brown L, Laferla FM, Armato U, Whitfield J (2010) Amyloid-beta peptides stimulate the expression of the p75(NTR) neurotrophin receptor in SHSY5Y human neuroblastoma cells and AD transgenic mice. J Alzheimers Dis 19:915\u2013925","journal-title":"J Alzheimers Dis"},{"key":"2864_CR33","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/s10495-005-2649-6","volume":"10","author":"S Giraud","year":"2005","unstructured":"Giraud S, Lautrette C, Bessette B, Decourt C, Mathonnet M, Jauberteau MO (2005) Modulation of Fas-induced apoptosis by p75 neurotrophin receptor in a human neuroblastoma cell line. Apoptosis 10:1271\u20131283","journal-title":"Apoptosis"},{"key":"2864_CR34","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3389\/fnagi.2013.00038","volume":"5","author":"J G\u00f6tz","year":"2013","unstructured":"G\u00f6tz J, Lim YA, Eckert A (2013) Lessons from two prevalent amyloidoses\u2014what amylin and A\u03b2 have in common. Front Aging Neurosci 5:38","journal-title":"Front Aging Neurosci"},{"key":"2864_CR35","first-page":"42","volume":"5","author":"W Fu","year":"2013","unstructured":"Fu W, Patel A, Jhamandas JH (2013) Amylin receptor: a common pathophysiological target in Alzheimer\u2019s disease and diabetes mellitus. Front Aging Neurosci 5:42","journal-title":"Front Aging Neurosci"},{"key":"2864_CR36","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ajpath.2010.11.022","volume":"178","author":"JH Jhamandas","year":"2011","unstructured":"Jhamandas JH, Li Z, Westaway D, Yang J, Jassar S, MacTavish D (2011) Actions of \u03b2-amyloid protein on human neurons are expressed through the amylin receptor. Am J Pathol 178:140\u2013149","journal-title":"Am J Pathol"},{"key":"2864_CR37","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000100355","volume":"4","author":"VH Finder","year":"2007","unstructured":"Finder VH, Glockshuber R (2007) Amyloid-beta aggregation. Neurodegener Dis 4:13\u201327","journal-title":"Neurodegener Dis"},{"key":"2864_CR38","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3233\/JAD-2004-6310","volume":"6","author":"E House","year":"2004","unstructured":"House E, Collingwood J, Khan A, Korchazkina O, Berthon G, Exley C (2004) Aluminium, iron, zinc and copper influence the in vitro formation of amyloid fibrils of Abeta42 in a manner which may have consequences for metal chelation therapy in Alzheimer\u2019s disease. J Alzheimers Dis 6:291\u2013301","journal-title":"J Alzheimers Dis"},{"key":"2864_CR39","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3389\/fnagi.2014.00237","volume":"6","author":"S Keskitalo","year":"2014","unstructured":"Keskitalo S, Farkas M, Hanenberg M, Szodorai A, Kulic L, Semmler A, Weller M, Nitsch RM, Linnebank M (2014) Reciprocal modulation of A\u03b242 aggregation by copper and homocysteine. Front Aging Neurosci 6:237. doi: 10.3389\/fnagi.2014.00237","journal-title":"Front Aging Neurosci"},{"key":"2864_CR40","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1093\/abbs\/gmt044","volume":"45","author":"Y Bin","year":"2013","unstructured":"Bin Y, Li X, He Y, Chen S, Xiang J (2013) Amyloid-\u03b2 peptide (1-42) aggregation induced by copper ions under acidic conditions. Acta Biochim Biophys Sin (Shanghai) 45:570\u2013577","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"2864_CR41","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/jnr.21135","volume":"85","author":"ML Giuffrida","year":"2007","unstructured":"Giuffrida ML, Grasso G, Ruvo M, Pedone C, Saporito A, Marasco D, Pignataro B, Cascio C, Copani A, Rizzarelli E (2007) Abeta(25-35) and its C- and\/or N-blocked derivatives: copper driven structural features and neurotoxicity. J Neurosci Res 85:623\u2013633","journal-title":"J Neurosci Res"},{"key":"2864_CR42","doi-asserted-by":"crossref","first-page":"811","DOI":"10.3233\/JAD-2009-1235","volume":"18","author":"E House","year":"2009","unstructured":"House E, Mold M, Collingwood J, Baldwin A, Goodwin S, Exley C (2009) Copper abolishes the beta-sheet secondary structure of preformed amyloid fibrils of amyloid-beta(42). J Alzheimers Dis 18:811\u2013817","journal-title":"J Alzheimers Dis"},{"key":"2864_CR43","doi-asserted-by":"crossref","unstructured":"Kandimalla R, Thirumala V, Reddy PH (2016) Is Alzheimer\u2019s disease a type 3 diabetes? A critical appraisal. Biochim Biophys Acta (in press)","DOI":"10.1016\/j.bbadis.2016.08.018"},{"key":"2864_CR44","doi-asserted-by":"crossref","first-page":"985845","DOI":"10.1155\/2015\/985845","volume":"2015","author":"S Rosales-Corral","year":"2015","unstructured":"Rosales-Corral S, Tan DX, Manchester L, Reiter RJ (2015) Diabetes and Alzheimer disease, two overlapping pathologies with the same background: oxidative stress. Oxid Med Cell Longev 2015:985845","journal-title":"Oxid Med Cell Longev"},{"key":"2864_CR45","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1586\/14789450.2013.841549","volume":"10","author":"F Despa","year":"2013","unstructured":"Despa F, Decarli C (2013) Amylin: what might be its role in Alzheimer\u2019s disease and how could this affect therapy? Expert Rev Proteomics 10:403\u2013405","journal-title":"Expert Rev Proteomics"},{"key":"2864_CR46","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nrneurol.2010.130","volume":"6","author":"C Sims-Robinson","year":"2010","unstructured":"Sims-Robinson C, Kim B, Rosko A, Feldman EL (2010) How does diabetes accelerate Alzheimer disease pathology? Nat Rev Neurol 6:551\u2013559","journal-title":"Nat Rev Neurol"},{"key":"2864_CR47","doi-asserted-by":"crossref","first-page":"711","DOI":"10.3233\/JAD-2010-100012","volume":"20","author":"CM Carlsson","year":"2010","unstructured":"Carlsson CM (2010) Type 2 diabetes mellitus, dyslipidemia, and Alzheimer\u2019s disease. J Alzheimers Dis 20:711\u2013722","journal-title":"J Alzheimers Dis"},{"key":"2864_CR48","doi-asserted-by":"crossref","first-page":"744","DOI":"10.4239\/wjd.v6.i5.744","volume":"6","author":"GR Sridhar","year":"2015","unstructured":"Sridhar GR, Lakshmi G, Nagamani G (2015) Emerging links between type 2 diabetes and Alzheimer\u2019s disease. World J Diabetes 6:744\u2013751","journal-title":"World J Diabetes"},{"key":"2864_CR49","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3390\/ijms17040503","volume":"17","author":"N Kimura","year":"2016","unstructured":"Kimura N (2016) Diabetes mellitus induces Alzheimer\u2019s disease pathology: histopathological evidence from animal models. Int J Mol Sci 17:503","journal-title":"Int J Mol Sci"},{"key":"2864_CR50","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2147\/CIA.S74042","volume":"10","author":"X Li","year":"2015","unstructured":"Li X, Song D, Leng SX (2015) Link between type 2 diabetes and Alzheimer\u2019s disease: from epidemiology to mechanism and treatment. Clin Interv Aging 10:549\u2013560","journal-title":"Clin Interv Aging"},{"key":"2864_CR51","doi-asserted-by":"crossref","first-page":"25945","DOI":"10.1074\/jbc.274.36.25945","volume":"274","author":"DM Walsh","year":"1999","unstructured":"Walsh DM, Hartley DM, Kusumoto Y, Fezoui Y, Condron MM, Lomakin A, Benedek GB, Selkoe DJ, Teplow DB (1999) Amyloid \u03b2 protein fibrillogenesis: structure and biological activity of protofibrillar intermediates. J Biol Chem 274:25945\u201325952","journal-title":"J Biol Chem"},{"key":"2864_CR52","doi-asserted-by":"crossref","first-page":"6448","DOI":"10.1073\/pnas.95.11.6448","volume":"95","author":"MP Lambert","year":"1998","unstructured":"Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M, Morgan TE, Rozovsky I, Trommer B, Viola KL, Wals P, Zhang C, Finch CE, Krafft GA, Klein WL (1998) Diffusible, nonfibrillar ligands derived from A\u03b21-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci USA 95:6448\u20136453","journal-title":"Proc Natl Acad Sci USA"},{"key":"2864_CR53","doi-asserted-by":"crossref","first-page":"11110","DOI":"10.1002\/anie.201305372","volume":"52","author":"LE Cassagnes","year":"2013","unstructured":"Cassagnes LE, Herv\u00e9 V, Nepveu F, Hureau C, Faller P, Collin F (2013) The catalytically active copper-amyloid-Beta state: coordination site responsible for reactive oxygen species production. Angew Chem Int Ed Engl 52:11110\u201311113","journal-title":"Angew Chem Int Ed Engl"},{"key":"2864_CR54","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/j.1471-4159.2006.03905.x","volume":"98","author":"EJ Coulson","year":"2006","unstructured":"Coulson EJ (2006) Does p75 neurotrophin receptor mediate A\u03b2-induced toxicity in Alzheimer\u2019s disease? J Neurochem 98:654\u2013660","journal-title":"J Neurochem"},{"key":"2864_CR55","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2174\/1568007054038210","volume":"4","author":"LF Lue","year":"2005","unstructured":"Lue LF, Yan SD, Stern DM, Walker DG (2005) Preventing activation of receptor for advanced glycation end products in Alzheimer\u2019s disease. Curr Drug Targets CNS Neurol Disord 4:249\u2013266","journal-title":"Curr Drug Targets CNS Neurol Disord"},{"key":"2864_CR56","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1523\/JNEUROSCI.0350-08.2008","volume":"28","author":"A Sotthibundhu","year":"2008","unstructured":"Sotthibundhu A, Sykes A, Fox B, Underwood CK, Thangnipon W, Coulson EJ (2008) \u03b2-Amyloid1\u201342 induces neuronal death through the p75 neurotrophin receptor. J Neurosci 28:3941\u20133946","journal-title":"J Neurosci"},{"key":"2864_CR57","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.neurobiolaging.2014.09.014","volume":"36","author":"M Murphy","year":"2015","unstructured":"Murphy M, Wilson YM, Vargas E, Munro KM, Smith B, Huang A, Li QX, Xiao J, Masters CL, Reid CA, Barrett GL (2015) Reduction of p75 neurotrophin receptor ameliorates the cognitive deficits in a model of Alzheimer\u2019s disease. Neurobiol Aging 36:740\u2013752","journal-title":"Neurobiol Aging"},{"key":"2864_CR58","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1517\/13543784.2015.1001490","volume":"24","author":"D Walker","year":"2015","unstructured":"Walker D, Lue LF, Paul G, Patel A, Sabbagh MN (2015) Receptor for advanced glycation end product modulators: a new therapeutic target in Alzheimer\u2019s disease expert. Opin Investig Drugs 24:393\u2013399","journal-title":"Opin Investig Drugs"},{"key":"2864_CR59","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1210\/en.2013-1658","volume":"155","author":"JJ Gingell","year":"2014","unstructured":"Gingell JJ, Burns ER, Hay DL (2014) Activity of pramlintide, rat and human amylin but not A\u03b21-42 at human amylin receptors. Endocrinology 155:21\u201326","journal-title":"Endocrinology"},{"key":"2864_CR60","doi-asserted-by":"crossref","first-page":"5579","DOI":"10.1523\/JNEUROSCI.1051-04.2004","volume":"24","author":"JH Jhamandas","year":"2004","unstructured":"Jhamandas JH, MacTavish D (2004) Antagonist of the amylin receptor blocks \u03b2-amyloid toxicity in rat cholinergic basal forebrain neurons. J Neurosci 24:5579\u20135584","journal-title":"J Neurosci"},{"key":"2864_CR61","doi-asserted-by":"crossref","first-page":"338","DOI":"10.2174\/13892037113149990051","volume":"14","author":"W Fu","year":"2013","unstructured":"Fu W, Jhamandas JH (2013) Role of amylin and its receptors in neurodegeneration. Curr Protein Pept Sci 14:338\u2013345","journal-title":"Curr Protein Pept Sci"},{"key":"2864_CR62","doi-asserted-by":"crossref","first-page":"10627","DOI":"10.1523\/JNEUROSCI.0620-09.2009","volume":"29","author":"JK Knowles","year":"2009","unstructured":"Knowles JK, Rajadas J, Nguyen TV, Yang T, LeMieux MC, Vander Griend L, Ishikawa C, Massa SM, Wyss-Coray T, Longo FM (2009) The p75 neurotrophin receptor promotes amyloid-beta(1-42)-induced neuritic dystrophy in vitro and in vivo. J Neurosci 29:10627\u201310637","journal-title":"J Neurosci"},{"key":"2864_CR63","doi-asserted-by":"crossref","first-page":"5149","DOI":"10.1523\/JNEUROSCI.4878-07.2008","volume":"28","author":"E Sturchler","year":"2008","unstructured":"Sturchler E, Galichet A, Weibel M, Leclerc E, Heizmann CW (2008) Site-specific blockade of RAGE-Vd prevents amyloid-beta oligomer neurotoxicity. J Neurosci 28:5149\u20135158","journal-title":"J Neurosci"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-016-2864-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11010-016-2864-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-016-2864-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T22:31:12Z","timestamp":1498343472000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11010-016-2864-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,1]]},"references-count":63,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["2864"],"URL":"https:\/\/doi.org\/10.1007\/s11010-016-2864-1","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,1]]}}}